Skip to main content

Table 4 Frequent co-occurring dyads (≥10 %) and observed and expected values

From: Multimorbidity in older adults: magnitude and challenges for the Brazilian health system

Frequent co-occurring dyads (n)

Observed (%)

Expected (%)

Observed/expected

95 % CI

HBP/spinal column disease (1591)

23.6

20.7

1.14

1.06–1.23

HBP/heart problem (1593)

22.3

16.4

1.37

1.26–1.48

HBP/cognitive impairment (1514)

19.9

18.9

1.05

0.97–1.15

HBP/eyesight problem (1547)

17.1

15.2

1.13

1.03–1.23

HBP/rheumatism (1592)

17.0

15.1

1.13

1.03–1.23

HBP/falls (1591)

16.8

15.5

1.09

1.00–1.19

Rheumatism/spinal column disease (1590)

16.1

10.2

1.58

1.43–1.74

Heart problem/spinal column disease (1591)

12.9

11.1

1.17

1.06–1.30

Spinal column disease/falls (1589)

12.9

10.5

1.23

1.11–1.37

HBP/urinary incontinence (1592)

12.8

11.4

1.11

1.01–1.23

Spinal column disease/eyesight problem (1545)

12.4

10.3

1.20

1.08–1.34

HBP/problem chewing food (1590)

11.5

7.4

1.55

1.38–1.75

Heart problem/cognitive impairment (1514)

11.4

10.1

1.13

1.01–1.26

Cognitive impairment/falls (1512)

11.3

9.5

1.18

1.06–1.33

Cognitive impairment/eyesight problem (1506)

11.2

9.4

1.19

1.06–1.33

Spinal column disease/cognitive impairment (1512)

11.1

12.8

0.87

0.78–0.97

HBP/depression (1512)

11.0

10.0

1.11

0.99–1.24

HBP/diabetes (1593)

11.0

8.4

1.32

1.17–1.48

Heart problem/eyesight problem (1547)

10.7

8.1

1.32

1.17–1.48

Rheumatism/falls (1590)

10.4

7.6

1.37

1.21–1.54

Eyesight problem/falls (1545)

10.4

7.7

1.34

1.19–1.52

Rheumatism/cognitive impairment (1513)

10.1

9.3

1.09

0.97–1.22

  1. % prevalence, CI confidence interval, n sample size available to analysis